| 000 | 04785naaaa2201537uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/45503 | ||
| 005 | 20220714163731.0 | ||
| 020 | _abooks978-3-03928-005-6 | ||
| 020 | _a9783039280056 | ||
| 020 | _a9783039280049 | ||
| 024 | 7 |
_a10.3390/books978-3-03928-005-6 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aWasan, Kishor _4auth _91577545 |
|
| 700 | 1 |
_aBadea, Ildiko _4auth _91577546 |
|
| 245 | 1 | 0 | _aDrug Delivery Technology Development in Canada |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (352 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aCanada continues to have a rich history of ground-breaking research in drug delivery within academic institutions, pharmaceutical industry and the biotechnology community. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _aencapsulation | ||
| 653 | _abiodistribution | ||
| 653 | _apharmaceutics | ||
| 653 | _atargeted therapies | ||
| 653 | _agambogic acid | ||
| 653 | _aGE11 peptide | ||
| 653 | _aformulation and dosage form development | ||
| 653 | _atransient modulation | ||
| 653 | _aROESY NMR spectroscopy | ||
| 653 | _abioaccessibility | ||
| 653 | _apolymeric micelle | ||
| 653 | _apharmacological Inhibitors of HIF-1 and STAT3 | ||
| 653 | _ananoparticles | ||
| 653 | _aVitamin D | ||
| 653 | _adrug discovery | ||
| 653 | _aEGFR-targeted therapy | ||
| 653 | _atranslational research | ||
| 653 | _aclinical trials | ||
| 653 | _adoxorubicin | ||
| 653 | _adissolution | ||
| 653 | _adrug development | ||
| 653 | _apermeation enhancers | ||
| 653 | _aCanada | ||
| 653 | _aplant | ||
| 653 | _aprimary central nervous system lymphomas | ||
| 653 | _aphotostabilizers | ||
| 653 | _ahead and neck squamous cell carcinoma | ||
| 653 | _amouse models | ||
| 653 | _adrug delivery systems | ||
| 653 | _amelphalan | ||
| 653 | _ahypoxia-induced chemoresistance | ||
| 653 | _askin | ||
| 653 | _avirus | ||
| 653 | _acircadian clock | ||
| 653 | _achild friendly formulation | ||
| 653 | _aadenanthin | ||
| 653 | _aco-delivery | ||
| 653 | _acanola oil deodorizer distillate | ||
| 653 | _aMetaplex | ||
| 653 | _ainnovation | ||
| 653 | _acontrolled drug delivery | ||
| 653 | _anifedipine | ||
| 653 | _aradiolabeling | ||
| 653 | _aamphotericin B | ||
| 653 | _abiological barriers | ||
| 653 | _ablood-brain barrier (BBB) | ||
| 653 | _abiologicals | ||
| 653 | _alipid nanoparticles | ||
| 653 | _aoral formulation | ||
| 653 | _aphytosterols | ||
| 653 | _amedical devices | ||
| 653 | _achronotherapy | ||
| 653 | _aoral | ||
| 653 | _acationic gemini surfactant | ||
| 653 | _aroute of administration | ||
| 653 | _adrug delivery | ||
| 653 | _aintra-arterial chemotherapy | ||
| 653 | _adeveloping world | ||
| 653 | _asustained delivery | ||
| 653 | _awater miscible solvents | ||
| 653 | _acombination therapy | ||
| 653 | _aantibodies | ||
| 653 | _athroughput | ||
| 653 | _amagnetic fields | ||
| 653 | _aliposomes | ||
| 653 | _amedulloblastoma | ||
| 653 | _adrug-resistant melanoma | ||
| 653 | _arosmarinic acid | ||
| 653 | _atopical formulation | ||
| 653 | _aTNO gastrointestinal model | ||
| 653 | _agastrointestinal simulator | ||
| 653 | _amalignant gliomas | ||
| 653 | _atransdermal drug delivery | ||
| 653 | _aoral delivery | ||
| 653 | _aprecision medicine | ||
| 653 | _a3D spheroid | ||
| 653 | _aflavonoids | ||
| 653 | _astaurosporine | ||
| 653 | _aDOX-Vit D | ||
| 653 | _aloading gradients | ||
| 653 | _abacteriophage | ||
| 653 | _aphospholipid complex | ||
| 653 | _atriggered drug release | ||
| 653 | _aHIF-1 | ||
| 653 | _aphage display | ||
| 653 | _apharmacokinetics | ||
| 653 | _aemulsion | ||
| 653 | _aquercetin | ||
| 653 | _acisplatin | ||
| 653 | _aparasitic infections | ||
| 653 | _aremote loading | ||
| 653 | _aHAV6 cadherin peptide | ||
| 653 | _ablood-brain barrier | ||
| 653 | _ainclusion complex | ||
| 653 | _atocopherols | ||
| 653 | _aSTAT3 | ||
| 653 | _aultrasound | ||
| 653 | _aliposome | ||
| 653 | _afungal infections | ||
| 653 | _amagnetic resonance imaging (MRI) | ||
| 653 | _aMG63 | ||
| 653 | _amodel orange juice | ||
| 653 | _aradiation | ||
| 653 | _acancer | ||
| 653 | _amefloquine | ||
| 653 | _asmall molecules | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1904 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/45503 _70 _zDOAB: description of the publication |
| 999 |
_c2983470 _d2983470 |
||